Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
CA 2294018 A1 · Owner: New England Medical Center Hospitals, Inc. · Inventors: Plaut, Andrew G.; Qiu, Jiazhou
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for substantially reducing the pathogenicity of an infectious agent without killing the infectious agent, by removing or degrading a surface protein of the infectious agent, by contacting the infectious agent with substantially pure, non-pasteurized, naturally occurring lactoferrin under conditions sufficient to remove or degrade the protein is disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.